You are here

Case Studies

Leveraging Competitor Data to Define Best-In-Class Inhibitor With an Improved Safety Window
Driving a Critical Go/No Go Decision After Ph1
Triage Targets for Multi-Targeting Biologic
Determining Optimal Drug Binding Parameters